Hyaluronan promotes tumor lymphangiogenesis and intralymphantic tumor growth in xenografts

Acta Biochimica et Biophysica Sinica

Volumn 37, Issue 9, 2005, Pages 601-606

  Guo, Li Xia ^a   Zou, Ke ^a   Ju, Ji Hang ^a   Xie, Hong ^a  

^a Shanghai Jiao Tong University Affiliated Sixth People s Hospital   (China)

Author keywords

Hyaluronan; Intralymphatic tumor growth; Tumor lymphangiogenesis

Indexed keywords

GLYCOPROTEIN; HYALURONIC ACID; XLKD1 PROTEIN, MOUSE;

ANIMAL; ARTICLE; BIOSYNTHESIS; C3H MOUSE; DRUG EFFECT; EXPERIMENTAL NEOPLASM; LYMPH NODE METASTASIS; LYMPH VESSEL; LYMPHANGIOGENESIS; MOUSE; PATHOLOGY; PATHOPHYSIOLOGY; XENOGRAFT;

ANIMALS; GLYCOPROTEINS; HYALURONIC ACID; LYMPHANGIOGENESIS; LYMPHATIC METASTASIS; LYMPHATIC VESSELS; MICE; MICE, INBRED C3H; NEOPLASMS, EXPERIMENTAL; TRANSPLANTATION, HETEROLOGOUS;

EID: 26944438021     PISSN: 16729145     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1745-7270.2005.00083.x     Document Type: Article

References (26)

1. Saharinen P, Tammela T, Karkkainen MJ, Alitalo K. Lymphatic vasculature: Development, molecular regulation and role in tumor metastasis and inflammation. Trends Immunol 2004, 25: 387-395
2. Pepper MS, Tille JC, Nisato R, Skobe M. Lymphangiogenesis and tumor metastasis. Cell Tissue Res 2003, 314: 167-177
3. Stacker SA, Achen MG, Jussila L, Baldwin ME, Alitalo K. Lymphangiogenesis and cancer metastasis. Nat Rev Cancer 2002, 2: 573-583
4. Mandriota SJ, Jussila L, Jeltsch M, Compagni A, Baetens D, Prevo R, Banerji S et al. Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis. EMBO J 2001, 20: 672-682
5. Skobe M, Hawighorst T, Jackson DG, Prevo R, Janes L, Velasco P, Riccardi L et al. Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nat Med 2001, 7: 192-198
6. Stacker SA, Caesar C, Baldwin ME, Thornton GE, Williams RA, Prevo R, Jackson DG et al. VEGF-D promotes the metastatic spread of tumor cells via the lymphatics. Nat Med 2001, 7: 186-191
7. He Y, Kozaki K, Karpanen T, Koshikawa K, Yla-Herttuala S, Takahashi T, Alitalo K. Suppression of tumor lymphangiogenesis and lymph node metastasis by blocking vascular endothelial growth factor receptor 3 signaling. J Natl Cancer Inst 2002, 94: 819-825
8. Krishnan J, Kirkin V, Steffen A, Hegen M, Weih D, Tomarev S, Wilting J et al. Differential in vivo and in vitro expression of vascular endothelial growth factor (VEGF)-C and VEGF-D in tumors and its relationship to lymphatic metastasis in immunocompetent rats. Cancer Res 2003, 63: 713-722
9. Karpanen T, Egeblad M, Karkkainen MJ, Kubo H, Yla-Herttuala S, Jaattela M, Alitalo K. Vascular endothelial growth factor C promotes tumor lymphangiogenesis and intralymphatic tumor growth. Cancer Res 2001, 61: 1786-1790
10. Toole BP. Hyaluronan promotes the malignant phenotype. Glycobiology 2002, 12: 37R-42R
11. Hayen W, Goebeler M, Kumar S, Riessen R, Nehls V. Hyaluronan stimulates tumor cell migration by modulating the fibrin fiber architecture. J Cell Sci 1999, 112: 2241-2251
12. Itano N, Atsumi F, Sawai T, Yamada Y, Miyaishi O, Senga T, Hamguchi M et al. Abnormal accumulation of hyaluronan matrix diminishes contact inhibition of cell growth and promotes cell migration. Proc Natl Acad Sci USA 2002, 99: 3609-3614
13. Zhang Y, Thant AA, Machida K, Ichigotani Y, Naito Y, Hiraiwa Y, Senga T et al. Hyaluronan-CD44s signaling regulates matrix metalloproteinase-2 secretion in a human lung carcinoma cell line QG90. Cancer Res 2002, 62: 3962-3965
14. Liu N, Gao F, Han Z, Xu X, Underhill CB, Zhang L. Hyaluronan synthase 3 overexpression promotes the growth of TSU prostate cancer cells. Cancer Res 2001, 61: 5207-5214
15. Simpson MA, Wilson CM, McCarthy JB. Inhibition of prostate tumor cell hyaluronan synthesis impairs subcutaneous growth and vascularization in immunocompromised mice. Am J Pathol 2002, 161: 849-857
16. Almendro N, Bellon T, Rius C, Lastres P, Langa C, Corbi A, Bernabeu C. Cloning of the human platelet endothelial cell adhesion molecule-1 promoter and its tissue-specific expression. Structural and functional characterization. J Immunol 1996, 157: 5411-5421
17. Prevo R, Banerji S, Ferguson DJ, Clasper S, Jackson DG. Mouse LYVE-1 is an endocytic receptor for hyaluronan in lymphatic endothelium. J Biol Chem 2001, 276: 19420-19430
18. Slevin M, West D, Kumar P, Rooney P, Kumar S. Hyaluronan, angiogenesis and malignant disease. Int J Cancer 2004, 109: 793-794
19. Li HF, Ling MY, Xie Y, Xie H. Establishment of a lymph node metastatic model of mouse hepatocellular carcinoma Hca-F cells in C3H/Hej mice. Oncol Res 1998, 10: 569-573
20. Savani RC, Cao G, Pooler PM, Zaman A, Zhou Z, DeLisser HM. Differential involvement of the hyaluronan (HA) receptors CD44 and receptor for HA-mediated motility in endothelial cell function and angiogenesis. J Biol Chem 2001, 276: 36770-36778
21. Banerji S, Ni J, Wang SX, Clasper S, Su J, Tammi R. Jones M et al. LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan. J Cell Biol 1999, 144: 789-801
22. Jackson DG. Biology of the lymphatic marker LYVE-1 and applications in research into lymphatic trafficking and lymphangiogenesis. APMIS 2004, 112: 526-538
23. Ferrara N, Gerber HP, LeCouter J. The biology of VEGF and its receptors. Nat Med 2003, 9: 669-676
24. Lokeshwar VB, Rubinowicz D, Schroeder GL, Forgacs E, Minna JD, Block NL, Nadji M et al. Stromal and epithelial expression of tumor markers hyaluronic acid and HYAL1 hyaluronidase in prostate cancer. J Biol Chem 2001, 276: 11922-11932
25. Williams CS, Leek RD, Robson AM, Banerji S, Prevo R, Harris AL, Jackson DG. Absence of lymphangiogenesis and intratumoural lymph vessels in human metastatic breast cancer. J Pathol 2003, 200: 195-206
26. Liotta LA, Kohn EC. The microenvironment of the tumour-host interface. Nature 2001, 411: 375-379